Ensign Peak Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,300
| Closed | -$304K | – | 1741 |
|
|
2023
Q3 | $304K | Hold |
16,300
| – | – | ﹤0.01% | 1690 |
|
|
2023
Q2 | $423K | Buy |
16,300
+1,400
| +9% | +$36.4K | ﹤0.01% | 1665 |
|
|
2023
Q1 | $428K | Buy |
14,900
+4,200
| +39% | +$121K | ﹤0.01% | 1670 |
|
|
2022
Q4 | $317K | Buy |
10,700
+4,600
| +75% | +$136K | ﹤0.01% | 1702 |
|
|
2022
Q3 | $145K | Hold |
6,100
| – | – | ﹤0.01% | 1988 |
|
|
2022
Q2 | $136K | Hold |
6,100
| – | – | ﹤0.01% | 1901 |
|
|
2022
Q1 | $153K | Hold |
6,100
| – | – | ﹤0.01% | 1946 |
|
|
2021
Q4 | $219K | Sell |
6,100
-9,700
| -61% | -$348K | ﹤0.01% | 1906 |
|
|
2021
Q3 | $672K | Hold |
15,800
| – | – | ﹤0.01% | 1557 |
|
|
2021
Q2 | $684K | Hold |
15,800
| – | – | ﹤0.01% | 1538 |
|
|
2021
Q1 | $644K | Hold |
15,800
| – | – | ﹤0.01% | 1553 |
|
|
2020
Q4 | $715K | Sell |
15,800
-200
| -1% | -$9.05K | ﹤0.01% | 1515 |
|
|
2020
Q3 | $566K | Hold |
16,000
| – | – | ﹤0.01% | 1500 |
|
|
2020
Q2 | $604K | Hold |
16,000
| – | – | ﹤0.01% | 1421 |
|
|
2020
Q1 | $463K | Hold |
16,000
| – | – | ﹤0.01% | 1410 |
|
|
2019
Q4 | $830K | Buy |
+16,000
| New | +$830K | ﹤0.01% | 1396 |
|